Navamedic ASA 2023 AR2
The report highlights Navamedic's financial and sustainability performance for the fiscal year 2023. The company achieved record revenues of NOK 512 million, representing a 34% year-over-year increase, and completed the acquisition of Sensidose AB. On the sustainability front, Navamedic joined the Science Based Targets initiative (SBTi) and implemented the World Favor system to calculate its Scope 1, 2, and 3 emissions. Key environmental initiatives included product packaging and transport optimization, while social efforts focused on public health programs like 'Lighter Together' and 'MyControl'. The company also launched its Supplier Code of Conduct to ensure ethical standards across its supply chain.
Company: Navamedic ASA
Sector: Health Care
Country: Norway
Year: 2023
Type: AR2
Pages: 96
Navamedic ASA
Annual Report
The report highlights Navamedic's financial and sustainability performance for the fiscal year 2023. The company achieved record revenues of NOK 512 million, representing a 34% year-over-year increase, and completed the acquisition of Sensidose AB. On the sustainability front, Navamedic joined the Science Based Targets initiative (SBTi) and implemented the World Favor system to calculate its Scope 1, 2, and 3 emissions. Key environmental initiatives included product packaging and transport optimization, while social efforts focused on public health programs like 'Lighter Together' and 'MyControl'. The company also launched its Supplier Code of Conduct to ensure ethical standards across its supply chain.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Employees